These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16475491)

  • 1. Cutaneous lupoid leishmaniasis: a case report.
    Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O
    Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report).
    Nilforoushzadeh MA; Sadeghian G; Jaffary F; Ziaei H; Shirani-Bidabad L; Mahzoni P
    Korean J Parasitol; 2008 Sep; 46(3):175-7. PubMed ID: 18830058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of erysipeloid cutaneous leishmaniasis: atypical and unusual clinical variant.
    Ceyhan AM; Yildirim M; Basak PY; Akkaya VB; Erturan I
    Am J Trop Med Hyg; 2008 Mar; 78(3):406-8. PubMed ID: 18337335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Layegh P; Yazdanpanah MJ; Vosugh EM; Pezeshkpoor F; Shakeri MT; Moghiman T
    Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An atypical case of cutaneous leishmaniasis caused by Leishmania infantum in Portugal.
    Lopes L; Vasconcelos P; Borges-Costa J; Soares-Almeida L; Campino L; Filipe P
    Dermatol Online J; 2013 Nov; 19(11):20407. PubMed ID: 24314782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
    Esfandiarpour I; Dabiri SH
    Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z; Nakhli A; Rassaii S
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract]   [Full Text] [Related]  

  • 8. Case report: Leishmaniasis of the upper lip.
    Veraldi S; Bottini S; Persico MC; Lunardon L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Nov; 104(5):659-61. PubMed ID: 17656118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of meglumine antimoniate in canine leishmaniasis.
    Lamothe J
    Vet Rec; 2004 Mar; 154(12):378. PubMed ID: 15074332
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
    Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T
    Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sporotrichoid cutaneous leishmaniasis].
    López-Escobar M; Drake-Monfort M; Salesa-Gutiérrez de Rozas R; Hermana-Ramírez S
    Actas Dermosifiliogr; 2007; 98(6):444-5. PubMed ID: 17663940
    [No Abstract]   [Full Text] [Related]  

  • 12. Rhinophymous leishmaniasis: A new variant.
    Ul Bari A; Ejaz A
    Dermatol Online J; 2009 Mar; 15(3):10. PubMed ID: 19379654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oriental sore: a case report.
    Asvesti C; Anastassiadis G; Kolokotronis A; Zographakis I
    Oral Surg Oral Med Oral Pathol; 1992 Jan; 73(1):56-8. PubMed ID: 1603565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early enlargement of an ulcerated area during leishmaniasis treatment with meglumine antimoniate in Brazil.
    Romero GA; Molinet FJ; Noronha EF
    Trans R Soc Trop Med Hyg; 2013 Apr; 107(4):266-8. PubMed ID: 23315614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated cutaneous leishmaniasis: a patient with 749 lesions.
    Sousa AQ; Pompeu MM; Sólon FR; Frutuoso MS; Teixeira MJ; Silva TM
    Braz J Infect Dis; 2006 Jun; 10(3):230. PubMed ID: 17568857
    [No Abstract]   [Full Text] [Related]  

  • 16. Lupoid leishmaniasis due to Leishmania major with remaining large scars: report of 2 cases.
    Sadeghian G; Ziaei H; Shirani-Bidabadi L; Nilforoushzadeh MA
    East Mediterr Health J; 2010 Mar; 16(3):344-5. PubMed ID: 20795453
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [N-methyl glucamine antimoniate or Glucantime].
    Rapp C; Simon F; Dordain ML
    Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.
    Munir A; Janjua SA; Hussain I
    Acta Dermatovenerol Croat; 2008; 16(2):60-4. PubMed ID: 18541100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis.
    Arevalo I; Tulliano G; Quispe A; Spaeth G; Matlashewski G; Llanos-Cuentas A; Pollack H
    Clin Infect Dis; 2007 Jun; 44(12):1549-54. PubMed ID: 17516397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.